MYC and renal cell carcinoma: The MYC pathway is known to be activated in most human RCC and thus has been an interesting target for developing RCC models in mice. Myc expression was driven by the kidney-specific GGT promoter coupled to the tetracycline transactivating gene (tTA) and the induction of Myc resulted in the fast development of RCC [38].